hit counter
AxoGen, Inc. (AXGN) Stock News Sentiment & Price - Sentifly
AXGN - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



AxoGen, Inc. (AXGN)

USA
Medical Appliances & Equipment
NASDAQ
AXGN Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
AXGN Latest news
GlobeNewsWire
Neutral
Axogen, Inc. to Participate at Jefferies London Healthcare Conference
2021-11-04 07:00

ALACHUA, Fla. and TAMPA, Fla., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, chairman, CEO and president, will present at the Jefferies London Healthcare Conference. The presentation is scheduled for Wednesday, November 17, 2021 at 4:25 p.m. (11:25 a.m. ET).

Seeking Alpha
Neutral
AxoGen's (AXGN) CEO Karen Zaderej on Q3 2021 Results - Earnings Call Transcript
2021-11-03 21:09

AxoGen's (AXGN) CEO Karen Zaderej on Q3 2021 Results - Earnings Call Transcript

Zacks Investment Research
Negative
AxoGen (AXGN) Reports Q3 Loss, Misses Revenue Estimates
2021-11-03 18:22

AxoGen (AXGN) delivered earnings and revenue surprises of 25.00% and -9.95%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Benzinga
Neutral
Axogen: Q3 Earnings Insights
2021-11-03 16:41

Axogen (NASDAQ:AXGN) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

GlobeNewsWire
Neutral
Axogen, Inc. Reports 2021 Third Quarter Financial Results
2021-11-03 16:01

ALACHUA, Fla. and TAMPA, Fla., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the third quarter ended September 30, 2021.

Zacks Investment Research
Positive
AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2021-10-27 16:12

AxoGen (AXGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire
Neutral
Axogen, Inc. to Report Third Quarter Financial Results and Host Conference Call on November 3, 2021
2021-10-13 07:00

ALACHUA, Fla. and TAMPA, Fla., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that it will report third quarter 2021 financial results on Wednesday, November 3, 2021 after the market closes. Axogen management will host an investment-community conference call and webcast following the release at 4:30 p.m. ET.

GlobeNewsWire
Neutral
Axogen to Participate in the 76th Annual Meeting of the American Society for Surgery of the Hand
2021-09-22 07:00

Industry leading nerve repair surgeons will share best practices and case studies during symposium session Industry leading nerve repair surgeons will share best practices and case studies during symposium session

GlobeNewsWire
Neutral
Axogen RECON(SM) Clinical Study Completes Subject Follow-up
2021-09-01 07:00

RECON is a pivotal study supporting the Company's Biologics License Application (BLA) for Avance® Nerve Graft RECON is a pivotal study supporting the Company's Biologics License Application (BLA) for Avance® Nerve Graft

Seeking Alpha
Positive
Axogen: Renewed Covid-19 Worries Hitting, But The Growth Story Is Very Appealing
2021-08-25 06:28

Axogen continues posting double-digit growth in volumes against 2019 levels despite trauma, breast recon, and oral-maxillofacial procedures still well below pre-pandemic levels.

Loading more news...